Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
Antioxidants · 06.02.2023 · 12 (2) · 396
DOI: 10.3390/antiox12020396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 06.02.2023. Verfasst von Xinyu Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, 2019 Wuhan Huanghe Talents Program, 2020 Wuhan medical research project.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a complex, multisystem disorder with both neurologic and systemic manifestations, which is usually associated with non-motor symptoms, including sleep disorders. Such associated sleep disorders are commonly observed as REM sleep behavior disorder, insomnia, sleep-related breathing disorders, excessive daytime sleepiness, restless legs syndrome and periodic limb movements. Melatonin has a wide range of regulatory effects, such as synchronizing circadian rhythm, and is expected to be a potential new circadian treatment of sleep disorders in PD patients. In fact, ongoing clinical trials with melatonin in PD highlight melatonin’s therapeutic effects in this disease. Mechanistically, melatonin plays its antioxidant, anti-inflammatory, anti-excitotoxity, anti-synaptic dysfunction and anti-apoptotic activities. In addition, melatonin attenuates the effects of genetic variation in the clock genes of Baml1 and Per1 to restore the circadian rhythm. Together, melatonin exerts various therapeutic effects in PD but their specific mechanisms require further investigations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Laboratory of Psychiatric Neurogenomics, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.
ORCID-Profile: Xinyu Hu, Hanshu Liu, Zhicheng Lin, Nian Xiong
Förderung
- National Natural Science Foundation of China
- 2019 Wuhan Huanghe Talents Program
- 2020 Wuhan medical research project
- 2021 Hubei Youth Top-notch Talent Training Program
- 2022 Outstanding Youth Project of Natural Science Foundation of Hubei province
Zitieren
APA
Hu, X., Li, J., Wang, X., Liu, H., Wang, T., Lin, Z., & Xiong, N. (2023). Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease. Antioxidants, 12(2), 396. https://doi.org/10.3390/antiox12020396
Vancouver
Hu X, Li J, Wang X, Liu H, Wang T, Lin Z, et al. Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease. Antioxidants. 2023;12(2):396. doi:10.3390/antiox12020396
BibTeX
@article{Hu2023,
author = {Hu, Xinyu and Li, Jingwen and Wang, Xinyi and Liu, Hanshu and Wang, Tao and Lin, Zhicheng and Xiong, Nian},
title = {Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {2},
pages = {396},
doi = {10.3390/antiox12020396}
}
EUVIMED